The U.S. Food and Drug Administration (FDA) is one of several federal organizations tasked with keeping American consumers safe from dangerous products. As its name implies, the agency is primarily responsible for ensuring the products meant to be consumed as food, drink, or medicine will not lead to serious illness or death. While the FDA is typically limited in its authority to order the recall of a particular product, manufacturers, producers, and distributors typically comply with requests and warnings by the administration. This week, however, one company is showing reluctance to issue a recall, despite claims by the FDA that a tablet intended for babies may contain a harmful substance.
Warnings Related to Belladonna
Near the end of last week, the FDA issued a public warning to parents regarding homeopathic teething products under the Hyland’s brand name. Specifically, the agency expressed concerns over inconsistent levels of belladonna in Hyland’s teething tablets. This marks the third warning pertaining belladonna by the FDA since 2010 and the second in four months. Belladonna is a toxic substance extracted from the nightshade plant and has been linked with nervous system problems, including seizures, spasms, hallucinations and death.